(Q30691130)

26 June 2017

title

Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire (English)

1 reference

26 June 2017

0 references

1 reference

7

Laura J Balcer

1 reference

26 June 2017

3

Steven L Galetta

1 reference

26 June 2017

Siu-Ling Ma

1

1 reference

26 June 2017

Judy A Shea

2

1 reference

26 June 2017

Dina A Jacobs

4

1 reference

26 June 2017

Clyde E Markowitz

5

1 reference

26 June 2017

Maureen G Maguire

6

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

American Journal of Ophthalmology

26 June 2017

published in

1 reference

26 June 2017

volume

133

1 reference

26 June 2017

issue

5

1 reference

26 June 2017

page(s)

686-692

1 reference

The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Optic nerve involvement and diplopia as initial manifestations of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Contrast sensitivity in multiple sclerosis. A study in 35 patients with and without optic neuritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Visual acuity and contrast sensitivity in multiple sclerosis--hidden visual loss: an auxiliary diagnostic test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

The 20/20 eye in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Self-reported visual dysfunction in multiple sclerosis: results from the 25-Item National Eye Institute Visual Function Questionnaire (VFQ-25)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Development of the 25-item National Eye Institute Visual Function Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Reported satisfaction, fluctuation of vision, and glare among patients one year after surgery in the Prospective Evaluation of Radial Keratotomy (PERK) Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

Standardizing the measurement of visual acuity for clinical research studies: Guidelines from the Eye Care Technology Forum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2802%2901337-5

10.1016/S0002-9394(02)01337-5

7 January 2021

Identifiers

DOI

1 reference

26 June 2017

1 reference